PTBP1 α3-Helix Derived Peptide P1 (TFA) mimics a structured recognition element from the α3-helix of PTBP1. Hydrophobic and polar residues participate in RNA-binding surface reconstruction. Researchers study its inhibitory potential and conformational ensemble. Applications include RNA-protein interaction analysis, helix-mimetic design, and structural mechanistic studies.
CAT No: R2834
PTBP1 α3-helix derived peptide P1(TFA) is a specialized synthetic peptide designed to mimic a specific α3-helix region of the polypyrimidine tract-binding protein 1 (PTBP1). As a crucial RNA-binding protein, PTBP1 plays a central role in the regulation of alternative splicing, mRNA stability, and various post-transcriptional processes. The P1(TFA) peptide, derived from the α3-helix domain, offers a unique tool for researchers aiming to dissect the structural and functional nuances of PTBP1 interactions with RNA and other cellular partners. Because of its targeted design, this peptide enables the exploration of molecular mechanisms underlying RNA-protein recognition and the modulation of splicing events, providing valuable insights into gene regulation at the RNA level.
Alternative Splicing Research: PTBP1 α3-helix derived peptide P1(TFA) is frequently utilized as a molecular probe in studies investigating alternative splicing mechanisms. By introducing this peptide into in vitro or cellular systems, researchers can competitively inhibit the interaction between endogenous PTBP1 and its RNA substrates, thereby elucidating the specific contributions of the α3-helix region to splice site selection and exon inclusion or exclusion. This approach has proven instrumental in mapping the functional domains of PTBP1 that are critical for its splicing regulatory activity, especially in the context of developmentally regulated or tissue-specific alternative splicing events.
RNA-Protein Interaction Studies: The P1(TFA) peptide serves as a valuable tool for dissecting the molecular basis of RNA-protein interactions involving PTBP1. Through techniques such as surface plasmon resonance, fluorescence anisotropy, or electrophoretic mobility shift assays, scientists can use this peptide to compete with full-length PTBP1 for RNA binding, thereby pinpointing the affinity and specificity determinants conferred by the α3-helix. These studies are essential for understanding how the modular architecture of PTBP1 governs its recognition of diverse RNA sequences and secondary structures, and they provide a foundation for the rational design of modulators that target RNA-binding domains.
Structural Biology and Protein Engineering: P1(TFA) is highly relevant in structural biology applications, where it can be used as a surrogate for the α3-helix in crystallographic or NMR studies. By isolating this helix-derived segment, researchers can analyze its conformational properties, stability, and potential for forming secondary structure in solution or when complexed with RNA or other proteins. Insights gained from such studies inform the broader field of protein engineering, enabling the design of synthetic peptides with enhanced stability, specificity, or altered binding profiles for biotechnological or research applications.
Screening for Small Molecule Modulators: The α3-helix derived peptide is an effective platform for high-throughput screening assays aimed at identifying small molecules or peptides that disrupt or stabilize PTBP1-RNA interactions. By using P1(TFA) as a competitive inhibitor in binding assays, researchers can evaluate the efficacy of candidate compounds in modulating the interaction interface defined by the α3-helix. This strategy accelerates the discovery of chemical probes that can serve as research tools for dissecting RNA processing pathways or as starting points for the development of new molecular modulators.
Biomolecular Interaction Mapping: The P1(TFA) peptide is also instrumental in mapping the network of protein-protein and protein-RNA interactions that involve the α3-helix region of PTBP1. By incorporating this peptide into pull-down assays, crosslinking experiments, or affinity purification protocols, scientists can identify novel partners and characterize the interaction surfaces critical for PTBP1 function. Such studies deepen our understanding of the dynamic assembly of ribonucleoprotein complexes and the molecular logic that governs post-transcriptional gene regulation.
In summary, PTBP1 α3-helix derived peptide P1(TFA) represents a versatile and powerful tool for advancing research in RNA biology, structural biochemistry, and molecular interaction analysis. Its application spans from probing the intricacies of alternative splicing regulation and RNA-protein recognition to facilitating the identification of new modulators and mapping complex biomolecular networks. By enabling precise dissection of the PTBP1 functional landscape, this peptide supports the development of innovative research strategies and the generation of high-impact scientific discoveries in the field of post-transcriptional gene regulation.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More